Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
152,733,167
-
Total 13F shares
-
84,610
-
Share change
-
-175,983
-
Total reported value
-
$57,544
-
Price per share
-
$0.68
-
Number of holders
-
11
-
Value change
-
-$119,036
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of PALISADE BIO, INC. - Common Stock, par value $0.01 (PALI) as of Q2 2025
As of 30 Jun 2025,
PALISADE BIO, INC. - Common Stock, par value $0.01 (PALI) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,610 shares.
The largest 10 holders included
XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, Newbridge Financial Services Group, Inc., Tower Research Capital LLC (TRC), Transce3nd, LLC, UBS Group AG, Federation des caisses Desjardins du Quebec, BANK OF AMERICA CORP /DE/, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.